Industry landscapes
The companies, capital and talent shaping age tech and longevity in the United States. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
61 of 1,115 tracked companies have open roles.
283 of 1,115 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 543 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 27.6% of disclosed capital, while 74.6% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $158.96M | 57 | 36 |
| 2017 | $136.58M | 75 | 40 |
| 2018 | $1.01B | 82 | 35 |
| 2019 | $327.1M | 88 | 42 |
| 2020 | $585.21M | 97 | 55 |
| 2021 | $1.53B | 65 | 55 |
| 2022 | $957.44M | 53 | 50 |
| 2023 | $453.79M | 38 | 50 |
| 2024 | $651.64M | 24 | 36 |
| 2025 | $826.22M | 11 | 43 |
Share of all disclosed company funding.
609 recorded rounds since 2016
Recorded participation in age tech and longevity company rounds since 2016.
Backed by Titanium Ventures and PruVen Capital and others.
Backed by .
Backed by .
Backed by .
Backed by .
Backed by Goldman Sachs and IVP and others.
Backed by .
Backed by .
Backed by Baillie Gifford and Marshall Wace and others.
Participating investors were not recorded in this snapshot.
Backed by General Atlantic and Generation Investment Management and others.
Backed by The Rise Fund and NewView Capital and others.
Backed by Insight Partners and General Atlantic and others.
Backed by TCG Ventures and SoftBank Vision Fund and others.
Backed by Baillie Gifford and Prosus and others.
Backed by FTV Capital and Forerunner Ventures.
Backed by Morgan Stanley and BlackRock and others.
Backed by aMoon and Luma Group and others.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2025 · company accounts; aggregate reporting threshold not met · 4 reporting entities from 9 eligible matches.
Sum of reporting-entity revenue; not the United States market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
None of 4 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2025 · 4 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| NU Skin ↗1021561 | $1,485.2m | $160.2m | +10.8% | — | — |
| LifeVantage ↗849146 | $228.5m | $9.8m | +4.3% | — | — |
| LogicMark ↗1566826 | $11.4m | $-7.5m | -65.4% | — | — |
| ELEVAI Labs ↗1840563 | $0.6m | $-7.7m | -1313.0% | — | — |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the the United States companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
21 of the 1,115 companies on this page carry a measured traffic record (1.9%); these are the largest of those, by monthly visits. The median among them is 258,682 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| AARPaarp.org | 26,519,628 | 82 | 63.1% |
| Find a Gravefindagrave.com | 16,643,133 | 74 | 67.8% |
| Care.comcare.com | 4,806,755 | 63 | 79.9% |
| OurTime Datingourtime.com | 2,482,995 | 53 | 71.2% |
| Inspira Financialinspirafinancial.com | 2,043,805 | 46 | 66.7% |
| Boldinboldin.com | 1,014,832 | 41 | 17.9% |
| NU Skinnuskin.com | 897,368 | 51 | 63.1% |
| ForeverMissedforevermissed.com | 499,064 | 42 | 72.1% |
| GoGoGrandparentgogograndparent.com | 326,397 | 41 | 81.7% |
| Rementoremento.co | 285,326 | 38 | 72.2% |
Visits and authority are third-party web estimates, not company-reported figures.
151 of these companies (13.5%) publish at least one Android app — 255 apps in all, carrying 25.3M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Dr. Blood Pressure: DiabetesHealthCast | 7.8M | 3.9 | Medical |
| AARP NowAARP | 5.5M | 4.7 | Lifestyle |
| Care.com: Hire CaregiversCare.com | 2.5M | 2.9 | Lifestyle |
| Ourtime : Dating App for 50+OurTime Dating | 1.8M | 3.1 | Dating |
| Care.com: Find Caregiver JobsCare.com | 1.5M | 4.6 | Lifestyle |
| Finhabits: Invest My MoneyFinhabits | 987.3K | 4.4 | Finance |
| Inspira Mobile™Inspira Financial | 677.3K | 2.3 | Finance |
| Senior Match: Mature DatingSeniorMatch | 629K | 3.6 | Dating |
| Find a GraveFind a Grave | 563.3K | 4.8 | Books & Reference |
| Nu Skin VeraNU Skin | 410.8K | 3.2 | Lifestyle |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Local Services | 44 | 13.8M | Dr. Blood Pressure: Diabetes 7.8M | |
| Healthcare Booking Platforms | 40 | 13M | Care.com: Hire Caregivers 2.5M | |
| Assistive Tech | 70 | 8.4M | Papa Pal: Find flexible work 246.7K | |
| Hrtech | 9 | 6.1M | AARP Now 5.5M | |
| Foundations | 4 | 5.7M | AARP SafeTrip™ 124.9K | |
| Online Mom & Baby Care | 6 | 4.1M | Care.com: Find Caregiver Jobs 1.5M | |
| Matchmaking | 7 | 2.8M | Ourtime : Dating App for 50+ 1.8M | |
| Investment Tech | 19 | 1.8M | Finhabits: Invest My Money 987.3K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 248 of 255 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
39 companies hiring · $3.28B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Manhattan Beach-headquartered private equity firm Pacific Avenue Capital Partners announced that an affiliate has entered into an agreement to acquire Care.com, a digital marketplace for caregiving services, from IAC Inc.
The round was led by Lifeline Ventures, known for backing companies such as Oura, Supercell, and Wolt in their early stages. Additional investors include Tiny VC, Wave Ventures, and First Fellow Partners, alongside several angel investors, including Cal Henderson, the co-founder of Slack.
Chptr, a storytelling platform helping funeral homes share memorial stories with the communities they serve, has raised $3.25M in funding according to a recent SEC filing.
Applied Digital plans to combine its cloud computing unit, Applied Digital Cloud, with EKSO.
LifeVantage and LoveBiome: LifeVantage acquired LoveBiome to expand its gut health portfolio.
CareScout has announced the acquisition of Seniorly (https://www.seniorly.com/).
Carepool Innovation Inc., whose medical rideshare platform automates medical transportation, has landed significant new funding from Decathlon Capital Partners. The multi-million-dollar investment package will support the expansion of Carepool into new geographic markets.
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the 'LOI') to acquire TELI Pharmaceuticals, Inc.
DUOS, a leading AI-powered digital health platform for member activation and benefits execution, today announced a $130 million strategic growth equity investment led by FTV Capital, a sector-focused growth equity firm with deep expertise in healthcare technology and services. The investment round also includes participation from Forerunner Ventures, DUOS’ earliest institutional investor, bringing the company full circle as it enters the next phase of growth.
Last month, Gusto, a payroll and HR software company, announced that it agreed to acquire Guideline, a startup offering retirement plans to small and medium businesses.
Top 10 categories among 220 recorded events in the 24-month window.
3 companies with recorded IPO activity
13 tracked people moves
Appointment President and Chief Executive Officer
Appointment Interim Chief Executive Officer
Retirement Previously Chief Executive Officer
Appointment Chief Operating Officer
Appointment Chief Marketing Officer
Resignation Previously Chief Financial Officer
Appointment interim Chief Financial Officer
Appointment General Counsel
Products, platforms and features in the recorded window
Analytics Service
Analytics Solution
Handheld wellness device
AI‑native foldable smartphone
AI device ecosystem platform
Electric car
4 recorded customer wins
Customer: nokiamobile
Customer: tui groupAutomotive
Customer: cloverdale foodsfood processing
Customer: Nevada Agency and Transfer CompanyCorporate Governance
1 companies with reported reductions
Scale not stated rolesregulatory uncertainty
1 recorded events
approvedFDA
1 tracked suits
corporate espionage and trade secret violationsCivil · Ongoing
Reported company results in the recorded window.
Median across 26 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| baker tilly→Vanilla ↗ | Announced | 2026-05-01 | Not stated in snapshot |
| pacific avenue capital partners→Care.com ↗ | Announced | 2026-04-01 | Not stated in snapshot |
| IAC Inc.→Care.com ↗ | Completed | 2026-04-01 | $500.0M |
| affiliate of Pacific Avenue Capital Partners→Care.com ↗ | Announced | 2026-03-02 | $320.0M |
| applied digital→Ekso Bionics ↗ | Announced | 2025-12-30 | Not stated in snapshot |
| LifeVantage→LoveBiome | Completed | 2025-12-16 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
1,049 postings in the preceding 12 months. The full 2,181-posting snapshot covers 117 employers.
77 tracked postings mention remote work.
589 postings specify a level.
Top skills across 2,181 tracked postings in the available jobs snapshot.
Median across 199 postings with pay data, expressed in USD.
| Company | Open roles |
|---|---|
| Medical Guardian ↗ | 12 |
| A Place for Mom ↗ | 11 |
| SafelyYou ↗ | 10 |
| Utah Retirement Systems ↗ | 10 |
| Care.com ↗ | 10 |
| AARP ↗ | 9 |
| The Helper Bees ↗ | 8 |
| IRA Financial ↗ | 7 |
| Company | Employees |
|---|---|
| AARP ↗ | 2,362 |
| Honor ↗ | 1,902 |
| NU Skin ↗ | 1,900 |
| Papa ↗ | 853 |
| Careforth ↗ | 580 |
| Human Interest ↗ | 577 |
| PCS Retirement ↗ | 341 |
| Life Alert ↗ | 304 |
754 founders and chief executives across 563 companies.
Co-Founder Comprehensive, ex-Co-Founder Thunder, SubProfile. Harvard University BA 2008
Ex -Co-Founder & CEO Meebo, Google. Yale University BA 2001, Stanford University Graduate School of Business MBA 2005
Ex-Co-Founder TaskRabbit, Humedica, Institute for Health Metrics, Founder LinkedUp. Fitchburg State University 2003…
Upside, ex-Motionpoint, ex-Zudy Software, University of Florida
Ex - President Stadion Money Management, Senior Vice President Lincoln Financial Group. University of Nebraska-Lincoln BS…
Ypo Ny Liberty, ex-Remedy Partners, ex-Complex Care Solutions, New York University - Stern School of Business, 2005
A Place For Mom, ex-American Express, ex-Comcast, Harvard Business School, 2016
Ex-Orpheris, Graybug Vision, Founder Versartis, PDMDC, Diartis Pharmaceuticals, BaroFold. University of California, Davis BS 1986, MIT PhD 1991
Duos, ex-Stealth Venture, ex-Rally Health, Saint John's University, 1970
Ex-WeWork, Aleph VC, eBay, Co-Founder The Gifts Project. Reichman University BA 2010, The Open University of Israel 2001
Founder Care, Ohai, ex-TheLadders, Upromise, Putnam Hayes & Bartlett. Mount Holyoke College BA 1993, HBS MBA 1998, Harvard Law School JD 1999
Jibe Ventures, ex-Wix, ex-Israeli Navy, The Interdisciplinary Center, 2012
101 profiles with education records.
28 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
11,793 papers in the recorded india scope.
Tone counts: 10,347 positive · 728 neutral · 718 negative.
Landmark: The Emerging Evidence of the Parkinson Pandemic
Landmark: Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation
Landmark: The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Common problems researchers identify · 0117.9% of this theme group
Immune system (34) · Disease (42) · Immunosenescence (20) · Neuroscience (21)
On the Immunological Theory of Aging
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview
| Year | Share index |
|---|---|
| 2022 | 3331.1 |
| 2023 | 3351.8 |
| 2024 | 3155.2 |
| 2025 | 3355.5 |
Common problems researchers identify · 0217.7% of this theme group
Senescence (204) · Cellular senescence (43) · Cell biology (61) · Phenotype (17)
Assessing Cell and Organ Senescence Biomarkers
Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities
| Year | Share index |
|---|---|
| 2022 | 1887.0 |
| 2023 | 2120.7 |
| 2024 | 1779.3 |
| 2025 | 1140.6 |
Common problems researchers identify · 0315.2% of this theme group
Gerontology (111) · Longevity (146) · Healthy aging (30) · Psychological intervention (27)
The Biology of Aging
Behavioral Aspects of Healthy Longevity
| Year | Share index |
|---|---|
| 2022 | 1861.3 |
| 2023 | 1835.4 |
| 2024 | 2189.6 |
| 2025 | 1418.9 |
Common problems researchers identify · 0413.3% of this theme group
Longevity (148) · Longevity risk (9) · Ecology (12) · Evolutionary biology (13)
The evolutionary ecology of senescence
On tree longevity
| Year | Share index |
|---|---|
| 2022 | 308.1 |
| 2023 | 286.8 |
| 2024 | 329.2 |
| 2025 | 215.5 |
Common problems researchers identify · 0512.5% of this theme group
Reproduction (25) · Fecundity (19) · Longevity (75) · Life history theory (10)
Life histories and the evolution of cooperative breeding in mammals
Insights from comparative analyses of aging in birds and mammals
| Year | Share index |
|---|---|
| 2022 | 248.2 |
| 2023 | 224.7 |
| 2024 | 235.1 |
| 2025 | 238.7 |
Common problems researchers identify · 0611.9% of this theme group
Demography (71) · Life expectancy (71) · Longevity (123) · Gerontology (44)
Measuring Recent Apparent Declines In Longevity: The Role Of Increasing Educational Attainment
Longer Lives, Sicker Lives? Increased Longevity and Extended Disability Among Mexican-Origin Elders
| Year | Share index |
|---|---|
| 2022 | 2006.4 |
| 2023 | 1968.6 |
| 2024 | 2304.2 |
| 2025 | 1509.2 |
Common problems researchers identify · 0711.5% of this theme group
Longevity (72) · Internal medicine (11) · Caloric theory (6) · Insulin (5)
Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in <i>C. elegans</i>
Sex Differences in Age Trajectories of Physiological Dysregulation: Inflammation, Metabolic Syndrome, and Allostatic Load
| Year | Share index |
|---|---|
| 2022 | 3042.4 |
| 2023 | 3309.9 |
| 2024 | 3010.0 |
| 2025 | 1891.9 |
Cautions · 0126.3% of this theme group
Longevity (74) · Fecundity (28) · Population (35) · Juvenile (12)
Cattle adapted to tropical and subtropical environments: genetic and reproductive considerations
Data from: Longevity of hymenopteran parasitoids in natural vs. agricultural habitats and implications for biological control
| Year | Share index |
|---|---|
| 2022 | 960.9 |
| 2023 | 945.1 |
| 2024 | 718.7 |
| 2025 | 546.3 |
Cautions · 0216.6% of this theme group
Senescence (65) · Cell biology (20) · Stem cell (10) · Progenitor cell (9)
Ageing compromises mouse thymus function and remodels epithelial cell differentiation
Congeneric variability in lifespan extension and onset of senescence suggest active regulation of aging in response to low temperature
| Year | Share index |
|---|---|
| 2022 | 2107.6 |
| 2023 | 2335.4 |
| 2024 | 2019.5 |
| 2025 | 1456.0 |
Cautions · 0316.0% of this theme group
Longevity (78) · Gerontology (20) · Life expectancy (14) · Demography (18)
Animal Models of Aging Research: Implications for Human Aging and Age-Related Diseases
Association Between Telomere Length, Specific Causes of Death, and Years of Healthy Life in Health, Aging, and Body Composition, a Populatio
| Year | Share index |
|---|---|
| 2022 | 2006.4 |
| 2023 | 1968.6 |
| 2024 | 2304.2 |
| 2025 | 1509.2 |
Cautions · 0413.2% of this theme group
Senescence (78) · Mesenchymal stem cell (15) · Cancer research (18) · Cell biology (25)
Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells
Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs an
| Year | Share index |
|---|---|
| 2022 | 1669.0 |
| 2023 | 2433.1 |
| 2024 | 1562.6 |
| 2025 | 1051.3 |
Cautions · 0511.3% of this theme group
Longevity (64) · Caenorhabditis elegans (12) · Drosophila melanogaster (9) · Genetics (8)
Uncoupling lifespan and healthspan in <i>Caenorhabditis elegans</i> longevity mutants
Metformin treatment of diverse <i>Caenorhabditis</i> species reveals the importance of genetic background in longevity and healthspan extens
| Year | Share index |
|---|---|
| 2022 | 2173.1 |
| 2023 | 2451.8 |
| 2024 | 2115.3 |
| 2025 | 1369.5 |
Cautions · 0611.3% of this theme group
Internal medicine (14) · Calorie restriction (8) · Endocrinology (10) · Caloric theory (6)
Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment
Measuring aging rates of mice subjected to caloric restriction and genetic disruption of growth hormone signaling
| Year | Share index |
|---|---|
| 2022 | 3267.9 |
| 2023 | 3524.0 |
| 2024 | 3220.3 |
| 2025 | 2011.0 |
Cautions · 075.3% of this theme group
Honey bee (8) · Pesticide (7) · Imidacloprid (6) · Brood (5)
Factors affecting the reproductive health of honey bee (Apis mellifera) drones—a review
Increase in longevity and amelioration of pesticide toxicity by natural levels of dietary phytochemicals in the honey bee, Apis mellifera
| Year | Share index |
|---|---|
| 2022 | 13.2 |
| 2023 | 12.9 |
| 2024 | 12.6 |
| 2025 | 12.3 |
Opportunities · 0118.8% of this theme group
Senescence (537) · Autophagy (101) · Internal medicine (108) · Oxidative stress (100)
Age-dependent effects of <i>Igf2bp2</i> on gene regulation, function, and aging of hematopoietic stem cells in mice
Disuse‐induced muscle fibrosis, cellular senescence, and senescence‐associated secretory phenotype in older adults are alleviated during re‐
| Year | Share index |
|---|---|
| 2022 | 3279.1 |
| 2023 | 3550.1 |
| 2024 | 3262.4 |
| 2025 | 2185.6 |
Opportunities · 0218.5% of this theme group
Senescence (1,008) · Cell biology (427) · Cellular senescence (189) · Phenotype (132)
Cellular Senescence and the Biology of Aging, Disease, and Frailty
Cellular senescence: from homeostasis to pathological implications and therapeutic strategies
| Year | Share index |
|---|---|
| 2022 | 1887.0 |
| 2023 | 2120.7 |
| 2024 | 1779.3 |
| 2025 | 1140.6 |
Opportunities · 0315.7% of this theme group
Senescence (831) · Cell biology (337) · Mesenchymal stem cell (60) · Inflammation (75)
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Cellular Senescence: Molecular Mechanisms, <i>In Vivo</i> Significance, and Redox Considerations
| Year | Share index |
|---|---|
| 2022 | 1939.0 |
| 2023 | 2169.3 |
| 2024 | 1827.4 |
| 2025 | 1231.2 |
Opportunities · 0415.1% of this theme group
Longevity (771) · Gerontology (121) · Demography (83) · Life expectancy (55)
The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals
Multi-omic underpinnings of epigenetic aging and human longevity
| Year | Share index |
|---|---|
| 2022 | 2006.4 |
| 2023 | 1968.6 |
| 2024 | 2304.2 |
| 2025 | 1509.2 |
Opportunities · 0512.1% of this theme group
Cancer research (388) · Cancer (170) · Senescence (480) · Tumor microenvironment (54)
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation
| Year | Share index |
|---|---|
| 2022 | 2019.0 |
| 2023 | 2800.3 |
| 2024 | 1954.8 |
| 2025 | 1639.8 |
Opportunities · 0610.5% of this theme group
Caenorhabditis elegans (182) · Longevity (504) · Drosophila melanogaster (90) · Drosophila (25)
Lysosomal signaling molecules regulate longevity in <i>Caenorhabditis elegans</i>
Genetics, Life Span, Health Span, and the Aging Process in Caenorhabditis elegans
| Year | Share index |
|---|---|
| 2022 | 55.2 |
| 2023 | 50.2 |
| 2024 | 54.4 |
| 2025 | 58.7 |
Opportunities · 079.2% of this theme group
Longevity (257) · Fecundity (46) · Honey bee (25) · Larva (24)
More on seed longevity phenotyping
Fluctuating thermal regimes extend longevity and maintain fecundity to increase shelf‐life of <i>Drosophila melanogaster</i> cultures
| Year | Share index |
|---|---|
| 2022 | 74.6 |
| 2023 | 63.5 |
| 2024 | 58.8 |
| 2025 | 56.8 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Promising | 37.9% | 36.9% |
| Breakthrough | 23.5% | 26.5% |
| Descriptive | 20.1% | 17.6% |
| Problem-identifying | 7.7% | 9.7% |
| Cautionary | 5.7% | 4.6% |
| Critical | 3.5% | 0.9% |
| Comparative | 1.6% | 3.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceSenescence, NK cells, and cancer: navigating the crossroads of aging and disease | 40 | 0.36% | 5 (12.5%) | 0.29% |
| Labour & data workTransportation Equity, Health, and Aging: A Novel Approach to Healthy Longevity with Benefits Across the Life Span | 9 | 0.08% | 5 (55.6%) | 0.22% |
| Safety & misuseTranscriptome of monocytes from liver, brain and bone marrow reveals organ-specific features in aging and alcohol misuse | 2 | 0.02% | 0 (0.0%) | 0.01% |
| Bias & fairnessThe False Promises of Working Longer | 1 | 0.01% | 1 (100.0%) | 0.03% |
| Concentration of compute powerDeep Brain Stimulation Battery Longevity: Comparison of Monopolar Versus Bipolar Stimulation Modes | 1 | 0.01% | 0 (0.0%) | 0.01% |
| Energy & datacenter footprint | 0 | 0.0% | 0 (%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
| Carbon & emissions of compute | 0 | 0.0% | 0 (%) | 0.0% |
| Hardware, e-waste & supply chain | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: United States. This may be broader than the company geography.
Compare demand signals in the United States’s newsflow with the age tech and longevity categories mapped to each signal.
Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.
The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.
Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.
Swipe horizontally to compare all columns →
| Signal family | Signal percentile | Supply percentile | Relative gap | Gap (points) | Signal share vs prior year |
|---|---|---|---|---|---|
| Mental health ↗Disease Burden | 78.6 | 66.7 | +11.9 | +63.1% | |
| Ageing & elder care ↗Disease Burden | 28.6 | 16.7 | +11.9 | -43.4% | |
| Air pollution ↗Environmental Driver | 21.4 | 16.7 | +4.7 | -18.3% | |
| Diabetes, hypertension & cardiac burden ↗Disease Burden | 21.4 | 100.0 | -78.6 | +21.4% | |
| Cancer burden ↗Disease Burden | 35.7 | — | No matching category | — | +2.5% |
| Infectious outbreaks ↗Disease Burden | 35.7 | — | No matching category | — | +45.9% |
| Maternal & child health ↗Disease Burden | 92.9 | — | No matching category | — | +110.1% |
| Layoffs & income shocks ↗Spending Pressure | 85.7 | — | No matching category | — | +57.7% |
Showing all 8 signals. Select a family for its history and mapped categories.
All 12 city readings for these demand families in the comparison geography. the United States is highlighted.
Each city’s reading is a share of its own coverage.
Maternal & child health · Mental health · Layoffs & income shocks
Maternal & child health · Ageing & elder care · Cancer burden
Maternal & child health · Mental health · Layoffs & income shocks
Maternal & child health · Mental health · Layoffs & income shocks
Mental health · Maternal & child health · Ageing & elder care
Maternal & child health · Layoffs & income shocks · Infectious outbreaks
Maternal & child health · Layoffs & income shocks · Mental health
Mental health · Maternal & child health · Air pollution
Maternal & child health · Mental health · Ageing & elder care
Maternal & child health · Mental health · Layoffs & income shocks
Layoffs & income shocks · Maternal & child health · Mental health
Mental health · Maternal & child health · Layoffs & income shocks
Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 1687 | 9.9 |
| 2024Q4 | 1832 | 10.33 |
| 2025Q1 | 1919 | 7.67 |
| 2025Q2 | 1464 | 9.19 |
| 2025Q3 | 4384 | 16.09 |
| 2025Q4 | 1521 | 12.6 |
| 2026Q1 | 2293 | 15.88 |
| 2026Q2 | 935 | 12.15 |
An ageing base can shift demand toward geriatric, home and chronic care.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 2092 | 12.27 |
| 2024Q4 | 3027 | 17.07 |
| 2025Q1 | 3166 | 12.65 |
| 2025Q2 | 2222 | 13.94 |
| 2025Q3 | 1801 | 6.61 |
| 2025Q4 | 1042 | 8.63 |
| 2026Q1 | 1294 | 8.96 |
| 2026Q2 | 689 | 8.95 |
Sustained air-quality stress can pull respiratory and cardiac care demand with it.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 1075 | 6.31 |
| 2024Q4 | 1445 | 8.15 |
| 2025Q1 | 1906 | 7.62 |
| 2025Q2 | 1572 | 9.86 |
| 2025Q3 | 1626 | 5.97 |
| 2025Q4 | 646 | 5.35 |
| 2026Q1 | 1076 | 7.45 |
| 2026Q2 | 627 | 8.14 |
Chronic cardiometabolic burden can turn into decades of management demand per patient.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 555 | 3.26 |
| 2024Q4 | 539 | 3.04 |
| 2025Q1 | 1017 | 4.06 |
| 2025Q2 | 693 | 4.35 |
| 2025Q3 | 908 | 3.33 |
| 2025Q4 | 805 | 6.67 |
| 2026Q1 | 637 | 4.41 |
| 2026Q2 | 413 | 5.36 |
Cancer burden can pull screening, diagnostics and oncology capacity demand.
This signal has no matching category in the page’s age tech and longevity market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 1087 | 6.38 |
| 2024Q4 | 1551 | 8.75 |
| 2025Q1 | 1616 | 6.46 |
| 2025Q2 | 1306 | 8.19 |
| 2025Q3 | 1646 | 6.04 |
| 2025Q4 | 1238 | 10.26 |
| 2026Q1 | 1114 | 7.72 |
| 2026Q2 | 624 | 8.11 |
Outbreak pressure can pull testing, surveillance and rapid-care demand at short notice.
This signal has no matching category in the page’s age tech and longevity market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 673 | 3.95 |
| 2024Q4 | 800 | 4.51 |
| 2025Q1 | 981 | 3.92 |
| 2025Q2 | 860 | 5.4 |
| 2025Q3 | 2650 | 9.72 |
| 2025Q4 | 465 | 3.85 |
| 2026Q1 | 440 | 3.05 |
| 2026Q2 | 368 | 4.78 |
Maternal and child burden can pull immunisation, nutrition and pediatric care demand.
This signal has no matching category in the page’s age tech and longevity market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 1333 | 7.82 |
| 2024Q4 | 1414 | 7.97 |
| 2025Q1 | 1962 | 7.84 |
| 2025Q2 | 1864 | 11.69 |
| 2025Q3 | 8009 | 29.39 |
| 2025Q4 | 1168 | 9.68 |
| 2026Q1 | 1109 | 7.68 |
| 2026Q2 | 919 | 11.94 |
Layoff cycles can pull discretionary spend back toward value offerings.
This signal has no matching category in the page’s age tech and longevity market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 2692 | 15.79 |
| 2024Q4 | 2657 | 14.98 |
| 2025Q1 | 3457 | 13.81 |
| 2025Q2 | 3055 | 19.17 |
| 2025Q3 | 6687 | 24.54 |
| 2025Q4 | 3761 | 31.16 |
| 2026Q1 | 2843 | 19.69 |
| 2026Q2 | 1885 | 24.49 |
the United States age tech and longevity coverage
Hypertension
7,315 citations in the snapshot
Circulation
6,114 citations in the snapshot
Circulation
4,494 citations in the snapshot
Circulation
4,422 citations in the snapshot
the United States coverage of this page's demand families
| Keyword | Recent articles | Prior articles | Share change |
|---|---|---|---|
| post-covid complications | 1,103 | 105 | 1194.7% |
| last-mile vaccine delivery | 145 | 23 | 677.0% |
| epidemic death tolls | 313 | 53 | 627.8% |
| snow rescue | 199 | 36 | 581.3% |
| disease outbreak deaths | 700 | 152 | 467.6% |
| contagion mortality rates | 220 | 49 | 453.3% |
Share changes describe coverage in the stated comparison periods, not search demand or market size.
Company counts, hiring and disclosed funding across the recorded hubs.
29.0% across the displayed hubs
4 companies hiring · $733.2M disclosed funding
Explore companies in New York City ↗25.5% across the displayed hubs
7 companies hiring · $1.2B disclosed funding
Explore companies in San Francisco ↗10.2% across the displayed hubs
2 companies hiring · $112.0M disclosed funding
Explore companies in Los Angeles ↗
9.0% across the displayed hubs
3 companies hiring · $240.1M disclosed funding
Explore companies in Seattle ↗
7.8% across the displayed hubs
1 companies hiring · $154.0M disclosed funding
Explore companies in Austin ↗
6.3% across the displayed hubs
0 companies hiring · $19.0M disclosed funding
Explore companies in Chicago ↗
6.3% across the displayed hubs
0 companies hiring · $7.8M disclosed funding
Explore companies in Houston ↗
5.9% across the displayed hubs
2 companies hiring · $67.0M disclosed funding
Explore companies in Boston ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 31 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗